News

Making the right contract development and manufacturing choice happens to be a pivotal decision for biopharmaceutical firms that happen to be embarking on projects pertaining to novel antibody development. With the sector’s rising demand when it comes to qualified multidisciplinary...

New recommendations from Imperial College London aim to boost competitiveness in the UK's biopharma and Medtech sectors. It assesses the value-added per capita in these sectors and provides insights into their needs, challenges, and opportunities. Technological solutions and policy...

BeiGene, a global biotechnology company, and DualityBio, a next-generation ADC company, announced an agreement for BeiGene to acquire an exclusive option for a global clinical and commercial license to an investigational, preclinical ADC therapy for patients with select solid...

Velocity Clinical Research, the leading multi-specialty clinical sites business, and Privia Health, a physician enablement company serving more than 3,700 providers and 4.4 million patients, today announced a partnership to open embedded clinical research sites within Privia’s practice network. The...

The fields of artificial intelligence (AI) and biotechnology are experiencing rapid advancements, and their convergence is expected to create significant opportunities in the future. The application of AI in biotechnology has the potential to accelerate drug discovery, provide precise...

Monash University- Australia has gone on to buy a prominent Parkville property that will go on to become a major addition to its campus, which is home to the world-leading Faculty of Pharmacy and Pharmaceutical Sciences, and thereby unprecedentedly...

The Coalition For Epidemic Preparedness Innovation in Norway and the Strategic Centre of Biomedical Advanced Vaccine Research and Development for Preparedness and Response have gone on to sign a Memorandum of Cooperation- MoC so as to strengthen the partnership...